India Globalization Capital, Inc. Stock Nyse
Equities
US45408X1000
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 1.24M 1.7M | Sales 2025 * | 1.4M 1.91M | Capitalization | 34.35M 46.94M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.4M | Net income 2025 * | -10M -13.67M | EV / Sales 2024 * | 27.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 24.6 x |
P/E ratio 2024 * |
-2.36
x | P/E ratio 2025 * |
-3.25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.56% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Richard Prins
CHM | Chairman | 67 | 07-04-30 |
Director/Board Member | 79 | 22-01-17 |
1st Jan change | Capi. | |
---|---|---|
+19.42% | 47.02B | |
+48.77% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.82% | 26.05B | |
-21.76% | 19.15B | |
+4.15% | 12.55B | |
+29.43% | 12.34B | |
-3.75% | 11.82B |